Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Contingent consideration liabilities by Year
Contingent consideration liabilities — Total year-end fair value ($M) ($M)
Pfizer Contingent consideration liabilities: $1,800M in FY2025, up 248.2% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Fair Value Measurements — Contingent Consideration.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Contingent consideration liabilities — Total year-end fair value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,800 | +248.2% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 517 | -25.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 692 | +7.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 645 | -7.5% | Form 10-K (filed 2024-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 697 | +1.2% | Form 10-K (filed 2023-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 689 | -3.1% | Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 711 | -28.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 988 | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer Contingent consideration liabilities ($M), annual FY2018–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/cc-liab-tot-ann
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.